The molecular biology of nasal polyposis
- PMID: 11892044
- DOI: 10.1007/s11882-001-0017-3
The molecular biology of nasal polyposis
Abstract
The molecular biologic events in the development of nasal polyps are now becoming unraveled. It appears that eosinophils are the dominant inflammatory cell present in this tissue. The events leading up to the extravasation of eosinophils into the lamina propria nasal polyps are regulated by the proinflammatory cytokines tumor necrosis factor-alpha and interleukin-1 beta. These cytokines upregulate very late antigen-4 on the surface of eosinophils and vascular cell adhesion molecule-1 on the surface of the endothelial blood vessel. Chemokines such as RANTES (regulated upon activation, normal T-cell expressed and secreted) and eotaxin are responsible for the movement of eosinophils into the lamina propria of the nasal polyp. The release of major basic protein has an effect on alteration of the epithelial architecture and on the sodium and chloride flux into and out of the apical epithelial cell of the tissue. Finally, the alteration of the surface epithelium results in a defect in the migration of the cystic fibrosis transmembrane regulator protein to the apical surface. These two events, the release of major basic protein from the eosinophil and the alteration of the architecture of the surface epithelium, lead to an increase in sodium absorption and resultant edema: the hallmark of the pathology of the nasal polyp.
Similar articles
-
IL-4 and TNF-alpha increased the secretion of eotaxin from cultured fibroblasts of nasal polyps with eosinophil infiltration.Rhinology. 2007 Sep;45(3):235-41. Rhinology. 2007. PMID: 17956026
-
Detection of the chemokine RANTES and endothelial adhesion molecules in nasal polyps.J Allergy Clin Immunol. 1996 Oct;98(4):766-80. doi: 10.1016/s0091-6749(96)70126-4. J Allergy Clin Immunol. 1996. PMID: 8876553
-
Quantitative analysis of eotaxin and RANTES messenger RNA in nasal polyps: association of tissue and nasal eosinophils.Laryngoscope. 2000 Aug;110(8):1353-7. doi: 10.1097/00005537-200008000-00025. Laryngoscope. 2000. PMID: 10942140
-
Nasal polyposis: an update: editorial review.Curr Opin Allergy Clin Immunol. 2003 Feb;3(1):1-6. doi: 10.1097/00130832-200302000-00001. Curr Opin Allergy Clin Immunol. 2003. PMID: 12582307 Review.
-
[Inflammatory mechanisms in nasal polyposis].Srp Arh Celok Lek. 2014 Nov-Dec;142(11-12):740-6. doi: 10.2298/sarh1412740p. Srp Arh Celok Lek. 2014. PMID: 25731009 Review. Serbian.
Cited by
-
Nasal polyposis: current trends.Indian J Otolaryngol Head Neck Surg. 2014 Jan;66(Suppl 1):16-21. doi: 10.1007/s12070-011-0427-z. Epub 2011 Dec 29. Indian J Otolaryngol Head Neck Surg. 2014. PMID: 24533355 Free PMC article. Review.
-
[Immunocytochemical detection of caspase 3 in various diseases of human nasal mucosa].HNO. 2009 May;57(5):466-72. doi: 10.1007/s00106-009-1905-4. HNO. 2009. PMID: 19387597 German.
-
Immunopathologic Role of Eosinophils in Eosinophilic Chronic Rhinosinusitis.Int J Mol Sci. 2022 Nov 1;23(21):13313. doi: 10.3390/ijms232113313. Int J Mol Sci. 2022. PMID: 36362100 Free PMC article. Review.
-
Maxillary sinuses microbiology from patients with chronic rhinosinusitis.Braz J Otorhinolaryngol. 2010 Sep-Oct;76(5):548-51. doi: 10.1590/S1808-86942010000500002. Braz J Otorhinolaryngol. 2010. PMID: 20963334 Free PMC article.
-
TNF-alpha G/A308 polymorphism association with nasal polyposis in North part of Iran.Eur Arch Otorhinolaryngol. 2018 Sep;275(9):2253-2257. doi: 10.1007/s00405-018-5059-4. Epub 2018 Jul 12. Eur Arch Otorhinolaryngol. 2018. PMID: 30003390